FASN and breast cancer: Importantly, in 1984, Ookhtens and colleagues demonstrated in vivo that most of the esterified FAs in tumors were derived from de novobiosynthesis [81], as confirmed few years later by Kuhajdaet al., who showed for the first time that tumor cells (breast cancer in this study) over-express fatty acid synthase (FASN) [82].